UBS Group’s Sanofi SNY Stock Holding History

UBS Group’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-32,700	Closed	-$1.54M	–	11108
2025 Q3	$1.54M	Buy	+32,700	New	+$1.58M	﹤0.01%	5204
2025 Q2	–	Sell	-30,000	Closed	-$1.66M	–	10797
2025 Q1	$1.66M	Buy	+30,000	New	+$1.62M	﹤0.01%	4859
2024 Q4	–	Sell	-10,000	Closed	-$576K	–	10355
2024 Q3	$576K	Buy	+10,000	New	+$540K	﹤0.01%	5115
2015 Q3	–	Sell	-400	Closed	-$20K	–	8613
2015 Q2	$20K	Sell	400 -5,300	-93%	-$269K	﹤0.01%	6872
2015 Q1	$282K	Sell	5,700 -2,300	-29%	-$110K	﹤0.01%	4606
2014 Q4	$365K	Buy	+8,000	New	+$388K	﹤0.01%	4482

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

UBS Group's SNY Position: Q2 2026 in Review

UBS Group increased its Sanofi (SNY) stake by 72% in Q2 2026, buying an estimated $31.7M and bringing the position to 1,693,442 shares worth $72.2M. The position accounts for 0.01% of the portfolio, ranked #1386.

UBS Group first reported a position in SNY in Q4 2014 and has held it in 47 quarters since. The position peaked at $89M in Q1 2015. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

UBS Group held 1,693,442 shares of Sanofi worth $72.2M as of Q2 2026.
UBS Group bought 709,596 Sanofi shares in Q2 2026, an estimated $31.7M.
Sanofi made up 0.01% of UBS Group's portfolio in Q2 2026, its #1386 holding.
UBS Group first reported a position in Sanofi in Q4 2014 and has held it in 47 quarters since.
UBS Group's Sanofi position peaked at $89M in Q1 2015.
716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.